Categories Prevention, Screening



Relevance: High


Strength of Science: Medium
12 May 2025
Study : Impact of mental healthcare among those with increased pancreatic cancer risk
Most relevant for: People with hereditary pancreatic cancer risk or strong family history of pancreatic cancer
Pancreatic cancer is often aggressive and diagnosed at a late stage, which can lead to uncertainty and fear. For those at risk due to a genetic mutation or family history, access to surveillance and mental health support is essential to help manage the emotional impact. (Posted 5/12/25)
READ MORE ›


Relevance: Medium-High


Strength of Science: Medium-High


Research Timeline: Post Approval
23 January 2025
Study : Risk of peritoneal cancer is low for people with an inherited BRCA mutation after surgery
Most relevant for: People with a BRCA1 or BRCA2 mutation who have had risk-reducing surgery to remove their ovaries
The risk of peritoneal cancer is low in people with an inherited BRCA1 or BRCA2 mutation after risk-reducing ovary removal (oophorectomy). The risk was even lower when risk-reducing surgery was done at a young age and after 2005 when removal of the fallopian tubes was included in the procedure. The findings of this research support the theory that like ovarian cancer, peritoneal cancer begins in the fallopian tubes and reinforces the age recommendation for surgery. (Posted 1/23/25)
Este artículo está disponible en español.
READ MORE ›


Relevance: Medium


Strength of Science: Medium-High


Research Timeline: Post Approval
8 October 2024
Study : More research points to the benefits of pancreatic cancer screening
Most relevant for: People undergoing pancreatic cancer screening
People with a family history of pancreatic cancer or those who have an inherited mutation that increases risk may benefit from yearly pancreatic cancer screening. Yearly screening may lead to early diagnosis and longer survival. (Posted 10/8/24)
Este artículo está disponible en español.
READ MORE ›


Relevance: Medium


Research Timeline: Post Approval
16 August 2024
Update : News from the FDA: Updates on breast cancer treatment
Most relevant for: People with BioZorb markers in breast tissue. People who will have a lumpectomy. People interested in cancer-related podcasts.
The FDA updates the risks of using BioZorb Markers and approves a new imaging drug for breast cancer. (Posted 8/16/24)
Este artículo está disponible en español.
READ MORE ›


Relevance: Medium-High


Strength of Science: Medium-High


Research Timeline: Human Research
24 June 2024
Study : Yearly breast MRI screening improves outcomes for women with inherited BRCA mutations
Most relevant for: People with a BRCA1 or BRCA2 mutation who are considering breast MRI screening
An international research study of yearly breast MRI screening among women with BRCA1 and BRCA2 gene mutations found that BRCA1 carriers who had MRI screenings were less likely to die of breast cancer than those who did not. Additional studies with more BRCA2 mutation carriers are needed to determine if yearly breast MRIs reduce deaths from breast cancer in this group. (Posted 6/24/24)
Este artículo está disponible en español.
READ MORE ›


Relevance: Medium
16 April 2024
Personal Story : Living a full life with Li-Fraumeni syndrome
Most relevant for: People with Li-Fraumeni syndrome
This XRAY review is about a five-time cancer survivor who has an inherited mutation in the TP53 gene. People with inherited mutations in TP53 have Li-Fraumeni syndrome, which is linked to a very high lifetime risk for many types of cancer. Here we share his inspiring story and provide more information on Li-Fraumeni syndrome. (Posted 4/16/24)
Este artículo está disponible en español.
READ MORE ›


Relevance: High


Strength of Science: High


Research Timeline: Post Approval
15 March 2024
Study : Genetic testing among people with cancer can find mutations that may affect treatment and prevention
Most relevant for: People diagnosed with cancer who have not yet had genetic testing
Despite national guidelines recommending genetic testing, less than 10 percent of eligible patients had genetic testing within two years after their cancer diagnosis. Among those who had testing, 10-30 percent had an inherited mutation that could affect their medical care. (Posted 3/15/2024)
Este artículo está disponible en español.
READ MORE ›


Relevance: Medium
21 February 2024
Update : News from the FDA– new breast cancer treatment, thermography warning and implant screening updates
Most relevant for: People with HR-positive and HER2-negative metastatic breast cancer. People with silicone breast implants. People considering thermography screening
This XRAY review is a summary of FDA breast cancer updates from July to December 2023. This includes a new drug approval and two consumer updates. (Posted 2/21/24)
Este artículo está disponible en español.
READ MORE ›


Relevance: Medium


Research Timeline: Human Research
31 January 2024
Update : A breast cancer vaccine for people with an inherited BRCA1, BRCA2 or PALB2 mutation
Most relevant for: People at increased risk for breast cancer undergoing prophylactic bilateral mastectomy due to an inherited mutation in BRCA1, BRCA2 or PALB2. People with TNBC who still have breast cancer after chemotherapy.
A breast cancer vaccine is showing promise in early clinical trials. Initially, the vaccine was tested in people with triple-negative breast cancer (TNBC) who were at high risk for recurrence. Now the vaccine is being tested to lower breast cancer risk among people with an inherited mutation in BRCA1, BRCA2 or PALB2. It is also being tested in people with triple-negative breast cancer who are at high risk for recurrence and are taking the immunotherapy drug Keytruda (pembrolizumab) after completing chemotherapy. (Posted 1/31/24)
Este artículo está disponible en español.
READ MORE ›


Relevance: Medium-High


Strength of Science: Medium-High


Research Timeline: Post Approval
Study : H. pylori bacteria infection and risk of stomach cancer in mutation carriers
Most relevant for: People who are at increased risk for stomach cancer due to an inherited mutation.
The results of a study in Japan show that people with a bacterial infection called H. pylori and an inherited mutation in an ATM, BRCA1, BRCA2 or PALB2 gene have a high risk of stomach cancer. (Posted 1/19/24)
Este artículo está disponible en español.
READ MORE ›